Dolby Laboratories, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 17, 2026 (22 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 28, 2026 | Rosenblatt | maintain | Buy → Buy | — | 55% |
| Jul 31, 2026 | Rosenblatt | maintain | Buy → Buy | — | 55% |
| Jun 15, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 56% |
| Jun 11, 2026 | Rosenblatt | maintain | Buy → Buy | — | 55% |
| Apr 27, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 56% |
| Jan 30, 2026 | Barrington Research | maintain | Outperform → Outperform | $90 | 56% |
| Jan 30, 2026 | Rosenblatt | maintain | Buy → Buy | $85 | 55% |
| Jan 26, 2026 | Barrington Research | maintain | Outperform → Outperform | $90 | 56% |
| Jan 22, 2026 | Rosenblatt | maintain | Buy → Buy | $85 | 55% |
| Nov 19, 2025 | Rosenblatt | maintain | Buy → Buy | $85 | 55% |
| Nov 19, 2025 | Barrington Research | maintain | Outperform → Outperform | $95 | 56% |
| Sep 12, 2025 | Barrington Research | maintain | Outperform → Outperform | $100 | 56% |
| Sep 5, 2025 | Baird | initiate | — → Neutral | $74 | 55% |
| Aug 15, 2025 | Tigress Financial | maintain | Buy → Buy | $114 | 55% |
| Aug 1, 2025 | Rosenblatt | maintain | Buy → Buy | $95 | 55% |
| Jun 13, 2025 | Rosenblatt | maintain | Buy → Buy | $95 | 55% |
| May 15, 2025 | Tigress Financial | maintain | Buy → Buy | $112 | 55% |
| May 2, 2025 | Barrington Research | maintain | Outperform → Outperform | $100 | 56% |
| May 2, 2025 | Rosenblatt | maintain | Buy → Buy | $95 | 55% |
| Feb 13, 2025 | Barrington Research | maintain | Outperform → Outperform | $100 | 56% |
| Jan 30, 2025 | Barrington Research | maintain | Outperform → Outperform | $100 | 56% |
| Jan 30, 2025 | Rosenblatt | maintain | Buy → Buy | $100 | 55% |
| Jan 27, 2025 | Barrington Research | maintain | Outperform → Outperform | $100 | 56% |
| Jan 23, 2025 | Rosenblatt | maintain | Buy → Buy | $100 | 55% |
| Nov 20, 2024 | Barrington Research | maintain | Outperform → Outperform | $100 | 56% |
| Nov 20, 2024 | Rosenblatt | maintain | Buy → Buy | $100 | 55% |
| Sep 20, 2024 | Barrington Research | maintain | Outperform → Outperform | $100 | 56% |
| Aug 9, 2024 | Barrington Research | maintain | Outperform → Outperform | $100 | 56% |
| Jun 7, 2024 | Rosenblatt | maintain | Buy → Buy | $98 | 55% |
| Jun 3, 2024 | Barrington Research | upgrade | Market Perform → Outperform | $100 | 56% |
| May 3, 2024 | Rosenblatt | maintain | Buy → Buy | $98 | 55% |
| Apr 29, 2024 | Rosenblatt | maintain | Buy → Buy | $98 | 55% |
| Jan 31, 2024 | Rosenblatt | reiterate | Buy → Buy | $98 | 55% |
| Dec 11, 2023 | Rosenblatt | reiterate | Buy → Buy | $98 | 55% |
| Nov 17, 2023 | Rosenblatt | reiterate | Buy → Buy | $98 | 55% |
| Aug 4, 2023 | Rosenblatt | maintain | Buy → Buy | $98 | 55% |
| Jul 28, 2023 | Rosenblatt | reiterate | Buy → Buy | $93 | 55% |
| Jun 1, 2023 | Rosenblatt | reiterate | Buy → Buy | $93 | 55% |
| Apr 26, 2023 | Rosenblatt | reiterate | — → Buy | $90 | 55% |
| Apr 14, 2023 | Tigress Financial | reiterate | — → Buy | $116 | 55% |
| Feb 3, 2023 | Rosenblatt | maintain | — → Buy | $90 | 55% |
| Nov 18, 2022 | Barrington Research | downgrade | Outperform → Market Perform | $0 | 56% |
| Nov 7, 2022 | Rosenblatt | maintain | — → Buy | $85 | 55% |
| Oct 14, 2022 | Tigress Financial | maintain | — → Buy | $116 | 55% |
| May 24, 2022 | Rosenblatt | initiate | — → Buy | $90 | 55% |
| Aug 2, 2021 | Barrington Research | upgrade | Market Perform → Outperform | $115 | 56% |
| Jan 29, 2021 | B. Riley Securities | maintain | — → Neutral | $89 | 55% |
| Jun 24, 2020 | B. Riley Securities | downgrade | Buy → Neutral | $72 | 55% |
| May 5, 2020 | JP Morgan | maintain | — → Overweight | $65 | 54% |
| May 5, 2020 | B. Riley Securities | maintain | — → Buy | $68 | 55% |
No cross-platform signals in the last 90 days